Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation

J. Bartkova, J. Lukas, M. Strauss, J. Bartek,

. 1998 ; 17 (8) : 1027-1037.

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

The mammalian D-type cyclins D1, D2, and D3 activate the cyclin-dependent kinases CDK4 and CDK6 in G1 and thereby promote the cell's commitment to enter S phase. To elucidate the extent of functional overlap among the D-type cyclins, we have examined several aspects of the least characterized member of this subfamily of G cyclin proteins, cyclin D3. Microinjection of cyclin D3-neutralizing antibody inhibited G1/S transition in human (IMR-90) and rat (R12) diploid fibroblasts, indicating that analogous to cyclins D1 and D2, cyclin D3 is essential for timely progression through G1. In contrast to cyclins D1 and D2, cyclin D3 was (i) ubiquitously expressed among a panel of 70 human cultured cell types; (ii) strongly upregulated upon induction of HL-60 leukaemia cells to differentiate; and (iii) accumulated to high levels in a wide range of quiescent cell types in mouse and human differentiated tissues. Complementary analyses of human biopsies and mouse tissues at different stages of foetal and postnatal development revealed lineage-dependent transient or long-term accumulation of the cyclin D3 protein, correlating with initiation/establishment or maintenance of the mature phenotypes, respectively. Our data support the notion that the biological roles of the individual D-type cyclins are not fully redundant, and suggest a possible dual role for cyclin D3 in cell proliferation and induction and/or maintenance of terminal differentiation.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15001033
003      
CZ-PrNML
005      
20151014103517.0
007      
ta
008      
150112s1998 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/sj.onc.1202016 $2 doi
035    __
$a (PubMed)9747882
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Bártková, Jiřina $7 xx0094304
245    10
$a Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation / $c J. Bartkova, J. Lukas, M. Strauss, J. Bartek,
520    9_
$a The mammalian D-type cyclins D1, D2, and D3 activate the cyclin-dependent kinases CDK4 and CDK6 in G1 and thereby promote the cell's commitment to enter S phase. To elucidate the extent of functional overlap among the D-type cyclins, we have examined several aspects of the least characterized member of this subfamily of G cyclin proteins, cyclin D3. Microinjection of cyclin D3-neutralizing antibody inhibited G1/S transition in human (IMR-90) and rat (R12) diploid fibroblasts, indicating that analogous to cyclins D1 and D2, cyclin D3 is essential for timely progression through G1. In contrast to cyclins D1 and D2, cyclin D3 was (i) ubiquitously expressed among a panel of 70 human cultured cell types; (ii) strongly upregulated upon induction of HL-60 leukaemia cells to differentiate; and (iii) accumulated to high levels in a wide range of quiescent cell types in mouse and human differentiated tissues. Complementary analyses of human biopsies and mouse tissues at different stages of foetal and postnatal development revealed lineage-dependent transient or long-term accumulation of the cyclin D3 protein, correlating with initiation/establishment or maintenance of the mature phenotypes, respectively. Our data support the notion that the biological roles of the individual D-type cyclins are not fully redundant, and suggest a possible dual role for cyclin D3 in cell proliferation and induction and/or maintenance of terminal differentiation.
650    _2
$a monoklonální protilátky $x chemie $7 D000911
650    _2
$a buněčná diferenciace $x fyziologie $7 D002454
650    _2
$a buněčné dělení $x fyziologie $7 D002455
650    _2
$a buněčné linie $7 D002460
650    _2
$a cyklin D3 $7 D056743
650    _2
$a cykliny $x biosyntéza $x imunologie $x fyziologie $7 D016213
650    _2
$a G1 fáze $x fyziologie $7 D016193
650    _2
$a HL-60 buňky $7 D018922
650    _2
$a lidé $7 D006801
650    _2
$a interfáze $x fyziologie $7 D007399
650    _2
$a akutní promyelocytární leukemie $x patologie $7 D015473
650    _2
$a kosterní svaly $x cytologie $x metabolismus $7 D018482
650    _2
$a orgánová specificita $7 D009928
650    _2
$a S fáze $x fyziologie $7 D016196
650    _2
$a nádorové buňky kultivované $7 D014407
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lukáš, Jiří $7 xx0094305
700    1_
$a Strauss, M
700    1_
$a Bártek, Jiří, $d 1953- $7 xx0046271
773    0_
$w MED00003600 $t Oncogene $x 0950-9232 $g Roč. 17, č. 8 (1998), s. 1027-1037
856    41
$u https://pubmed.ncbi.nlm.nih.gov/9747882 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150112 $b ABA008
991    __
$a 20151014103707 $b ABA008
999    __
$a ok $b bmc $g 1058121 $s 883751
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 1998 $b 17 $c 8 $d 1027-1037 $i 0950-9232 $m Oncogene $n Oncogene $x MED00003600
LZP    __
$a Pubmed-20150112

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...